Alan Burke is a Pharmacology and Toxicology Associate in the Office of Technology Development. Alan joined OTD in May 2022.

Alan graduated from Columbia University with a PhD in Molecular Pharmacology and Therapeutics, working on bispecific antibodies for acute myeloid leukemia. Alan received a BS in Biomedical Engineering from Case Western Reserve University.